Tumor-specific donor lymphocyte infusion therapy with allogeneic T cells utilizing novel retrovirus vector silencing endogenous TCR expression

Ítems similars

• A Promising Vector for TCR Gene Therapy: Differential Effect of siRNA, 2A Peptide, and Disulfide Bond on the Introduced TCR Expression
  per: Okamoto, Sachiko, et al.
  Publicat: (2012)
• In vivo persistence of adoptively transferred TCR gene-transduced lymphocytes with anti-tumor reactivity in patients with MAGE-A4 expressing esophageal cancer
  per: Ikeda, Hiroaki, et al.
  Publicat: (2013)
• Efficient tumor regression by adoptively transferred CEA-specific CAR-T cells associated with symptoms of mild cytokine release syndrome
  per: Wang, Linan, et al.
  Publicat: (2016)
• P71. Adoptive transfer of TCR gene-transduced lymphocytes targeting MAGE-A4 for refractory esophageal cancer
  per: Shiku, H, et al.
  Publicat: (2014)
• Adoptive transfer of genetically modified Wilms' tumor 1–specific T cells in a novel malignant skull base meningioma model
  per: Iwami, Kenichiro, et al.
  Publicat: (2013)